Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.8M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Feb 18 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 1,244 | $473.68 | $589.3K | -7.3% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 2,476 | $489.46 | $1.2M | -12.7% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 1,505 | $483.75 | $728K | -7.2% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | AGRANT◷ | 4,135 | — | — | +24.6% | Open the original filing on SEC.gov |
| Feb 13 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 988 | $499.00 | $493K | -5.5% | Open the original filing on SEC.gov |
| Feb 13 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 2,993 | $487.76 | $1.5M | -14.4% | Open the original filing on SEC.gov |
| Feb 11 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 1,925 | $460.43 | $886.3K | -8.5% | Open the original filing on SEC.gov |
| Feb 10 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 1,630 | $468.41 | $763.5K | -6.7% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 2,774 | — | — | +12.8% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 6,294 | — | — | +41.1% | Open the original filing on SEC.gov |
| Dec 3, 2025 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 347 | $449.00 | $155.8K | -2.2% | Open the original filing on SEC.gov |